Showing results (1161-1170 of 5,723) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|May 6, 2018
Check point inhibitors a new era in renal cell carcinoma treatmentMohamed Alsharedi, Heather Katz
Medical Oncology (Northwood, London, England)|May 7, 2018
Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumorsVishal Jindal, Ena Arora, Sorab Gupta
Medical Oncology (Northwood, London, England)|August 18, 2018
Sorafenib in patients with progressed and refractory bone tumorsAnna Raciborska, Katarzyna Bilska
Medical Oncology (Northwood, London, England)|August 18, 2018
Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissuesAnchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura, et al.
Medical Oncology (Northwood, London, England)|August 18, 2018
Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patientsTzu-Yao Liao, Chuang-Chi Liaw, Ke-Hung Tsui, et al.
Medical Oncology (Northwood, London, England)|August 18, 2018
Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patientsAkie Watanabe, Chang Cheng Yang, Winson Y Cheung
Medical Oncology (Northwood, London, England)|August 22, 2018
Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapyGuillaume Klausner, Eivind Blais, Raphaël Jumeau, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Significance of introduction of alternative dosing schedule for sunitinib during first-line treatment of patients with metastatic renal cell carcinomaHideaki Miyake, Yuto Matsushita, Hiromitsu Watanabe, et al.
Medical Oncology (Northwood, London, England)|June 11, 2014
Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinomaJun-li Wang, Le-gen Nong, Yu-jin Tang, et al.
Pageof 573